Top compounds associated with response to SIRPG


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib GDSC1000 pan-cancer AAC 0.078 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.052 0.1
mRNA Vorinostat gCSI pan-cancer AAC -0.076 0.1
mRNA LBW242 CCLE pan-cancer AAC 0.073 0.1
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.046 0.1
mRNA tigecycline CTRPv2 pan-cancer AAC 0.069 0.1
mRNA Crizotinib CTRPv2 pan-cancer AAC 0.046 0.1
mRNA PD-0332991 CCLE pan-cancer AAC 0.073 0.1
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.052 0.1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.1
Download CSV